Replies to post #391234 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

The institutions follow the rules. They dinner necessarily overly follow the rules or run up costs for filings they do not need to make. But most likely they are not buying.

In addition, hedge funds are NOT public and live to do things secretly, so it is right up their alley to not file. Same with family funds. Why would they publicize if they do not need to do so otherwise?

Hedge funds are not mutual funds. Neither are family funds. They try to limit disclosures not maximize them. They try to limit their regulatory overhead, not over do it.

Plus you have offshore family funds and hedge funds that would not want to file at all as well. In fact I traced one short who I think also may have traded NWBO years ago to a Hong Kong based big family fund office. I think he was always a short trader though, so I doubt he ever held a position that would need to be disclosed. The fund’s position is always as a “shareholder advocate” and he always was negative. Had some connections to big US banks and US mutual fund complexes, from his past work and maybe some ongoing relationships. So you never know.

[JerryCampbell]

I think you are confusing multiple topics.

SEC 13-F filings are required if a stock is on the 13-F list. That is the ultimate source for most website listings of institutional holdings.

That is a separate concept from an investment fund staying true to its mandate. That is between the fund and its investors. Public funds generally report full holdings to investors on a regular basis.

If nwbo TLD is successful, it likely sells itself. Otherwise, it would need to raise an enormous amount of funds to ramp up production and distribution, starting from scratch as it has no proven expertise in those areas.